|
|
|
Insider
Information: |
Glass J Kenneth |
Relationship: |
Director |
City: |
Memphis |
State: |
TN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
583,456 |
|
Indirect Shares
|
169,939 |
|
|
Direct
Value |
$7,359,079 |
|
|
Indirect Value
|
$1,634,430 |
|
|
Total
Shares |
753,395 |
|
|
Total
Value |
$8,993,509 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
First Horizon National Corporation |
FHN |
Director |
2007-02-20 |
394,689 |
2007-02-20 |
104,889 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
Director |
2016-03-01 |
183,767 |
2016-03-01 |
65,050 |
Premium* |
|
Fedex Corp |
FDX |
Director |
2003-12-31 |
5,000 |
2003-12-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONCT |
Oncternal Therapeutics In... |
Director |
|
2004-03-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2004-07-01 |
4 |
A |
$10.46 |
$5,000 |
D/D |
478 |
2,478 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2004-10-01 |
4 |
A |
$12.02 |
$5,000 |
D/D |
416 |
2,894 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2005-01-01 |
4 |
A |
$13.49 |
$5,000 |
D/D |
371 |
3,265 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2005-04-01 |
4 |
A |
$9.10 |
$5,000 |
D/D |
549 |
3,814 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2005-07-01 |
4 |
A |
$9.94 |
$5,000 |
D/D |
503 |
4,317 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2005-09-30 |
4 |
A |
$9.31 |
$5,000 |
D/D |
537 |
4,854 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2006-04-01 |
4 |
A |
$10.92 |
$5,000 |
D/D |
458 |
5,973 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2006-05-16 |
4 |
B |
$8.98 |
$91,094 |
D/D |
10,000 |
15,973 |
2.39 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2006-07-01 |
4 |
A |
$9.10 |
$5,000 |
D/D |
549 |
16,523 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2006-10-01 |
4 |
A |
$9.24 |
$5,000 |
D/D |
541 |
17,064 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-01-01 |
4 |
A |
$17.84 |
$5,000 |
D/D |
280 |
17,344 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-04-01 |
4 |
A |
$20.40 |
$5,000 |
D/D |
245 |
17,589 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-05-07 |
4 |
A |
$19.87 |
$199,086 |
D/D |
10,000 |
27,589 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-05-15 |
4 |
A |
$18.12 |
$173,334 |
D/D |
9,500 |
37,589 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-05-15 |
4 |
A |
$18.23 |
$9,115 |
D/D |
500 |
33,089 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-07-01 |
4 |
A |
$16.19 |
$5,000 |
D/D |
309 |
37,898 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-09-30 |
4 |
A |
$16.28 |
$2,250 |
D/D |
138 |
38,036 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-10-01 |
4 |
A |
$16.28 |
$5,000 |
D/D |
307 |
38,344 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2007-12-31 |
4 |
A |
$14.35 |
$3,000 |
D/D |
209 |
38,553 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2009-01-28 |
4 |
B |
$10.65 |
$53,243 |
D/D |
5,000 |
43,553 |
2.39 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2009-02-12 |
4 |
B |
$10.27 |
$51,350 |
D/D |
5,000 |
48,553 |
2.39 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2010-06-22 |
4 |
B |
$2.70 |
$20,250 |
D/D |
7,500 |
56,053 |
2.39 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2011-04-15 |
4 |
B |
$3.83 |
$57,443 |
D/D |
15,000 |
71,053 |
2.39 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2011-06-06 |
4 |
B |
$6.27 |
$100,634 |
D/D |
16,050 |
87,103 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|